New Delhi, Aug 12 (PTI) Aurobindo Pharma on Saturday said its consolidated net profit increased 10 per cent to Rs 571 crore in the first quarter ended June 30, 2023, on account of robust sales across regions.

The drug firm had reported a net profit of Rs 520.5 crore in April-June 2022-23. Revenue from operations rose to Rs 6,850.5 crore from Rs 6,236 crore in the year-ago period, the Hyderabad-based firm said in a statement.

Also Read | UPSC Recruitment 2023: Vacancies Notified for 30 Junior Scientific Officer, Specialist Grade III and Other Posts, Apply Online at upsc.gov.in.

With the product pipeline continuing to advance, and execution of growth drivers proceeding as planned, the company is confident that its fundamental strengths position it to create an upward trajectory, Vice-Chairman and Managing Director K Nithyananda Reddy said.

"Looking ahead, we are confident in executing our growth initiatives and creating long-term value for our shareholders," Reddy said. PTI MSS

Also Read | Independence Day 2023 Special: How Indian Armed Forces Grew Since 1947 To Become World’s 4th Best and Strongest Military Today.

(The above story is verified and authored by Press Trust of India (PTI) staff. PTI, India’s premier news agency, employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.. The views appearing in the above post do not reflect the opinions of LatestLY)